Ovid Therapeutics Inc. (OVID)

CIK 1636651 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ovid Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 24, 20261440001311404-26-000007
Aug 14, 20261440001311404-26-000005
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000926
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003432
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097342
Aug 14, 2026SCHEDULE 13G/A0001580642-26-005303
Aug 13, 20268-K0001628280-26-056497
Aug 13, 202610-Q0001628280-26-056498
Aug 13, 2026SCHEDULE 13G/A0001011438-26-000510
Jul 29, 2026SCHEDULE 13G0002012383-26-002922
Jul 8, 2026SCHEDULE 13G/A0001623632-26-000990
Jul 8, 202640001779359-26-000004
Jul 8, 202630001779359-26-000002
Jul 8, 20268-K0001628280-26-047584
Jun 17, 202640002138163-26-000005
Jun 17, 202630002138163-26-000003
Jun 11, 20268-K0001628280-26-042396
Jun 3, 20268-K0001628280-26-040038
May 15, 2026SCHEDULE 13G0001580642-26-003200
May 15, 2026SCHEDULE 13G/A0000919574-26-003481
May 15, 2026SCHEDULE 13G0000919574-26-003209
May 15, 2026SCHEDULE 13G0001193125-26-225184
May 14, 2026SCHEDULE 13G/A0001011438-26-000317
May 14, 2026SCHEDULE 13G/A0001256153-26-000006
May 12, 20268-K0001628280-26-033859